Low serum complement levels for C4 and C3 in patients with SLE can be triggered by a combination of heritable and acquired factors: genetic deficiencies, low copy number of complement C4 genes, robust consumption caused by immune complex-mediated complement activation, or the presence of inhibitors that inactivate or prevent accessibility. The gene discussed is C4A; the disease is systemic lupus erythematosus.